Proteome Sciences PLC
LSE:PRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Proteome Sciences PLC
Cash Equivalents
Proteome Sciences PLC
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Proteome Sciences PLC
LSE:PRM
|
Cash Equivalents
£781k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-8%
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Cash Equivalents
£181.1m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Genedrive PLC
LSE:GDR
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Cash Equivalents
£252k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Proteome Sciences PLC
Glance View
Proteome Sciences Plc engages in the applied proteomics and peptidomics services and applications. The company is headquartered in Addlestone, Surrey and currently employs 27 full-time employees. The firm is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. The company operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. The company has research agreements with various institutions in the United States.
See Also
What is Proteome Sciences PLC's Cash Equivalents?
Cash Equivalents
781k
GBP
Based on the financial report for Dec 31, 2025, Proteome Sciences PLC's Cash Equivalents amounts to 781k GBP.
What is Proteome Sciences PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-8%
Over the last year, the Cash Equivalents growth was -31%. The average annual Cash Equivalents growth rates for Proteome Sciences PLC have been -42% over the past three years , -19% over the past five years , and -8% over the past ten years .
